{"disease":{"id":"respiratory-tract-viral-infection","name":"respiratory tract viral infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05321433","title":"Tobacco Use and the Risk of COVID-19 and Adverse Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":757585,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT07249996","title":"Respiratory Infections in Young Children","phase":"","overall_status":"RECRUITING","enrollment_count":1088,"lead_sponsor_name":"Eduardo Lopez -Medina","has_results":false},{"nct_id":"NCT04611061","title":"Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers","phase":"","overall_status":"COMPLETED","enrollment_count":204,"lead_sponsor_name":"Nearmedic Plus LLC","has_results":false},{"nct_id":"NCT04815018","title":"Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2","phase":"","overall_status":"TERMINATED","enrollment_count":185,"lead_sponsor_name":"Pathnostics","has_results":false},{"nct_id":"NCT04365101","title":"Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":86,"lead_sponsor_name":"Celularity Incorporated","has_results":false},{"nct_id":"NCT04626622","title":"Kagocel® for the Prevention of ARVI and Influenza in Young People","phase":"","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Nearmedic Plus LLC","has_results":false},{"nct_id":"NCT06248983","title":"Transmission Of Respiratory Tract microOrganisms In a School Environment","phase":"","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT06149494","title":"RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Altesa Biosciences, Inc.","has_results":false},{"nct_id":"NCT03389997","title":"Assessement of Viral Shedding Duration After a Respiratory Tract Infection in Oncology and Hematology Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Poitiers University Hospital","has_results":false},{"nct_id":"NCT04933968","title":"Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"AlloVir","has_results":true},{"nct_id":"NCT05090475","title":"Implementation of Academic Detailing Interventions on Prescribing of Antimicrobial Drugs in Primary Health Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"General Hospital Koprivnica","has_results":false},{"nct_id":"NCT04664075","title":"Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)","phase":"","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Imperial College London","has_results":true}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}